Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 15
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Genome editing of human pancreatic beta cell models: problems, possibilities and outlook

  • Balboa, Diego
  • Prasad, Rashmi B.
  • Groop, Leif
  • Otonkoski, Timo
Understanding the molecular mechanisms behind beta cell dysfunction is essential for the development of effective and specific approaches for diabetes care and prevention. Physiological human beta cell models are needed for this work. We review the possibilities and limitations of currently available human beta cell models and how they can be dramatically enhanced using genome-editing technologies. In addition to the gold standard, primary isolated islets, other models now include immortalised human beta cell lines and pluripotent stem cell-derived islet-like cells. The scarcity of human primary islet samples limits their use, but valuable gene expression and functional data from large collections of human islets have been made available to the scientific community. The possibilities for studying beta cell physiology using immortalised human beta cell lines and stem cell-derived islets are rapidly evolving. However, the functional immaturity of these cells is still a significant limitation. CRISPR-Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated protein 9) has enabled precise engineering of specific genetic variants, targeted transcriptional modulation and genome-wide genetic screening. These approaches can now be exploited to gain understanding of the mechanisms behind coding and non-coding diabetes-associated genetic variants, allowing more precise evaluation of their contribution to diabetes pathogenesis. Despite all the progress, genome editing in primary pancreatic islets remains difficult to achieve, an important limitation requiring further technological development., The authors’ work in this area has been supported by grants from the Academy of Finland, The Novo Nordisk Foundation and the Sigrid Jusélius Foundation. TO is also funded by the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement no. 115797 (INNODIA), which receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA), JDRF and the Leona M. and Harry B. Helmsley Charitable Trust.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

An integrated multi-omics approach identifies the landscape of interferon-α-mediated responses of human pancreatic beta cells

  • Colli, Maikel Luis
  • Ramos-Rodríguez, Mireia
  • Raurell Vila, Helena
  • Pasquali, Lorenzo
  • Eizirik, Décio L.
Interferon-α (IFNα), a type I interferon, is expressed in the islets of type 1 diabetic individuals, and its expression and signaling are regulated by T1D genetic risk variants and viral infections associated with T1D. We presently characterize human beta cell responses to IFNα by combining ATAC-seq, RNA-seq and proteomics assays. The initial response to IFNα is characterized by chromatin remodeling, followed by changes in transcriptional and translational regulation. IFNα induces changes in alternative splicing (AS) and first exon usage, increasing the diversity of transcripts expressed by the beta cells. This, combined with changes observed on protein modification/degradation, ER stress and MHC class I, may expand antigens presented by beta cells to the immune system. Beta cells also up-regulate the checkpoint proteins PDL1 and HLA-E that may exert a protective role against the autoimmune assault. Data mining of the present multi-omics analysis identifies two compound classes that antagonize IFNα effects on human beta cells., This work was supported by grants from the Fonds National de la Recherche Scientifique (FNRS), Welbio CR-2015A-06 and CR-2019C-04, Belgium; the Horizon 2020 Program, T2Dsystems (GA667191); the National Institutes of Health, NIH-NIDDK-HIRN Consortium 1UC4DK104166-01 and Innovate2CureType1 - Dutch Diabetes Research Fundation (DDRF). D.L.E. and P.M. have received funding from the Innovative Medicines Initiative 2 Joint Undertaking under Grant Agreement No. 115797 (INNODIA). This Joint Undertaking receives support from the Union’s Horizon 2020 research and innovation programme and “EFPIA”, “JDRF” and “The Leona M. and Harry B. Helmsley Charitable Trust”. The DiViD study is funded by The South-Eastern Norway Regional Health Authority (grant to K.D.-J.), the Novo Nordisk Foundation (grant to K.D.-J.), and through the PEVNET (Persistent Virus Infection in Diabetes Network) Study Group funded by the European Union’s Seventh Framework Programme (FP7/2007-2013) under grant Agreement Number 261441 PEVNET. Additional support was from a JDRF Career Development Award (5-CDA-2014-221-A-N) to S.J.R., a JDRF research grant awarded to the network of Pancreatic Organ Donors – Virus (nPOD-V) consortium (JDRF 25-2012-516); an MRC Project Grant MR/P010695/1 awarded to S.J.R. and N.G.M., a studentship grant from the Norman Family Trust (to S.J.R. and N.G.M.), a Spanish Ministry of Economy and Competiveness (SAF2017-86242-R to L.P.) and Marató TV3 (201624.10 to L.P.). L.P. is a recipient of a Ramon y Cajal contract from the Spanish Ministry of Economy and Competitiveness (RYC-2013-12864) and M.R. is supported by an FI Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) PhD fellowship.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

The impact of proinflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes

  • Ramos-Rodríguez, Mireia
  • Raurell Vila, Helena
  • Colli, Maikel Luis
  • Alvelos, Maria Inês
  • Subirana-Granés, Marc
  • Juan-Mateu, Jonàs
  • Norris, Richard
  • Turatsinze, Jean-Valery
  • Nakayasu, Ernesto S.
  • Webb-Robertson, Bobbie-Jo M.
  • Inshaw, Jamie R. J.
  • Marchetti, Piero
  • Piemonti, Lorenzo
  • Esteller, Manel
  • Todd, John A.
  • Metz, Thomas O.
  • Eizirik, Décio L.
  • Pasquali, Lorenzo
The early stages of type 1 diabetes (T1D) are characterized by local autoimmune inflammation and progressive loss of insulin-producing pancreatic β cells. Here we show that exposure to proinflammatory cytokines reveals a marked plasticity of the β-cell regulatory landscape. We expand the repertoire of human islet regulatory elements by mapping stimulus-responsive enhancers linked to changes in the β-cell transcriptome, proteome and three-dimensional chromatin structure. Our data indicate that the β-cell response to cytokines is mediated by the induction of new regulatory regions as well as the activation of primed regulatory elements prebound by islet-specific transcription factors. We find that T1D-associated loci are enriched with newly mapped cis-regulatory regions and identify T1D-associated variants disrupting cytokine-responsive enhancer activity in human β cells. Our study illustrates how β cells respond to a proinflammatory environment and implicate a role for stimulus response islet enhancers in T1D., L.Pasquali was supported by grants from the Spanish Ministry of Economy and Competitiveness (nos. BFU2014-58150-R and SAF2017-86242-R), Marató TV3 (no. 201624.10) and a young investigator award from the Spanish Society of Diabetes (Ayuda SED a Proyectos de Investigación, no. 2017-SED). L.Pasquali is a recipient of a Ramon y Cajal contract from the Spanish Ministry of Economy and Competitiveness (no. RYC-2013-12864). The Pasquali lab is further supported by Instituto de Salud Carlos III (no. PIE16/00011). M.R. is supported by an FI Agència de Gestió d’Ajuts Universitaris i de Recerca PhD fellowship (no. 2019FI_B100203). J.J. was supported by a Marie Skłodowska-Curie Actions fellowship grant from the Horizons 2020 European Union (EU) Programme (project no. 660449). M.I.A. was supported by a FRIA fellowship from the Fonds de la Recherche Scientifique (FNRS) (no. 26410496). Human islets were provided through the European Consortium for Islet Transplantation distribution program for basic research supported by JDRF (no. 31-2008-416). D.L.E. was supported by the Walloon Region through the FRFS-WELBIO Fund for Strategic Fundamental research (no. CR-2015A-06s and CR-2019C-04) and by grants from the Fonds National de la Recherche Scientifique (no. T003613F), the Horizon 2020 Programme (project T2Dsystems, no. GA667191), Brussels Capital Region Innoviris (project DiaType, no. 2017-PFS-24), Dutch Diabetes Research Fundation (project Innovate2CureType1, DDRF; no. 2018.10.002) and the Innovative Medicines Initiative 2 Joint Undertaking (project INNODIA, no. 115797). This Innovative Medicines Initiative 2 Joint Undertaking receives support from the EU’s Horizon 2020 Research and Innovation Programme and European Federation of Pharmaceutical Industries and Associations, JDRF and the Leona M. and Harry B. Helmsley Charitable Trust (project INNODIA, no. 115797). T.O.M. and D.L.E. were supported by a grant from the National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases-Human Islet Research Network Consortium (no. 1UC4DK104166-01). Part of the work was performed at the Environmental Molecular Sciences Laboratory, a US Department of Energy national scientific user facility located at Pacific Northwest National Laboratory. Battelle operates the Pacific Northwest National Laboratory for the Department of Energy (contract no. DE-AC05-76RLO01830).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

The type 1 diabetes gene TYK2 regulates β-cell development and its responses to interferon-α

  • Chandra, Vikash
  • Ibrahim, Hazem
  • Halliez, Clémentine
  • Prasad, Rashmi B.
  • Vecchio, Federica
  • Dwivedi, Om Prakash
  • Kvist, Jouni
  • Balboa, Diego
  • Saarimäki-Vire, Jonna
  • Montaser, Hossam
  • Barsby, Tom
  • Lithovius, Väinö
  • Artner, Isabella
  • Gopalakrishnan, Swetha
  • Groop, Leif
  • Mallone, Roberto
  • Eizirik, Décio L.
  • Otonkoski, Timo
Type 1 diabetes (T1D) is an autoimmune disease that results in the destruction of insulin producing pancreatic β-cells. One of the genes associated with T1D is TYK2, which encodes a Janus kinase with critical roles in type-Ι interferon (IFN-Ι) mediated intracellular signalling. To study the role of TYK2 in β-cell development and response to IFNα, we generated TYK2 knockout human iPSCs and directed them into the pancreatic endocrine lineage. Here we show that loss of TYK2 compromises the emergence of endocrine precursors by regulating KRAS expression, while mature stem cell-islets (SC-islets) function is not affected. In the SC-islets, the loss or inhibition of TYK2 prevents IFNα-induced antigen processing and presentation, including MHC Class Ι and Class ΙΙ expression, enhancing their survival against CD8+ T-cell cytotoxicity. These results identify an unsuspected role for TYK2 in β-cell development and support TYK2 inhibition in adult β-cells as a potent therapeutic target to halt T1D progression., We gratefully acknowledge Dr. Fatoumata Samassa for help with cytotoxicity assays. We thank Jarkko Ustinov for the insulin and c-peptide ELISA measurements. S. Eurola, H. Grym, and A. Laitinen are thanked for expert technical support. We thank FIMM Single Cell Analytics unit (supported by HiLIFE and Biocentre Finland) for single cell RNA sequencing services. We want to acknowledge the participants and investigators of the FinnGen study. T.O. acknowledges the funding provided by the Academy of Finland (MetaStem Center of Excellence grant 312437), the Novo Nordisk Foundation and the Sigrid Juselius Foundation. R.M. acknowledges the support of the Agence Nationale de la Recherche (ANR-19-CE15-0014-01) and the Fondation pour la Recherche Medicale (EQU20193007831). C.H. was funded by an Année Recherche fellowship of the Paris Saclay University. F.V. was funded by an international PhD fellowship of the IdEx Université de Paris. R.B.P. acknowledges the funding by Hjelt foundation, Crafoord foundation (2020089) and Swedish Research Council (2021-02623). D.L.E. acknowledges the support of grants from the Welbio-FNRS (Fonds National de la Recherche Scientifique; WELBIO-CR-2019C-04), Belgium; the Innovate2CureType1—Dutch Diabetes Research Foundation (DDRF), Holland; the Juvenile Diabetes Foundation (JDRF; 2-SRA-2019-834-S-B); the NIH (HIRN-CBDS) grant U01 DK127786, USA. D.L.E., T.O., and R.M. acknowledge support from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreements No 115797 (INNODIA) and 945268 (INNODIA HARVEST), supported by the European Union’s Horizon 2020 research and innovation programme. These Joint Undertakings receive support from the Union’s Horizon 2020 research and innovation programme and “EFPIA”, “JDRF” and “The Leona M. and Harry B. Helmsley Charitable Trust”.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Rheological Behavior of Oil Well Cement Slurries with Addition of Core/Shell TiO2@SiO2 Nanoparticles—Effect of Superplasticizer and Temperature

  • Batista, Giovanni dos Santos
  • Puertas, Francisca
  • Takimi, Antonio Shigueaki
  • Costa, Eleani Maria da
  • Palacios, Marta
This study investigates the rheological behavior of oil well cement pastes (OWCPs) modified with core/shell TiO2@SiO2 (nTS) nanoparticles and polycarboxylate-ether (PCE) superplasticizers at different temperatures (25, 45, and 60 °C). Results show that nTS particles increased static and dynamic yield stresses and the apparent viscosity of the cement slurries due to an increased solid volume fraction and reduced free water availability. The increase in the slurry dispersion by adding PCE superplasticizers enhanced the effect of the nanoparticles on the rheological parameters. Oscillation rheometry demonstrated that nTS nanoparticles enhanced the structural buildup, while PCE retarded hydration. Furthermore, slurries hydrated at 60 °C experienced higher initial values of the elastic modulus and a faster exponential increase in this rheological parameter due to the acceleration of the cement hydration., This research was partly funded by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil (CAPES), grant number 001 and PID2020-115797RB-I00/AEI/10.13039/501100011033 (RHEODUR) project., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Research data Set de datos (Dataset)

Surface properties of clinker phases and clay minerals characterized by inverse gas chromatography (IGC) and their link to reactivity

  • Zunino, Franco
  • Palacios, Marta
  • Bowen, Paul
  • Scrivener, Karen L.
[Description of methods used for collection/generation of data] IGC measurements at infinite dilution (IGC-ID) and finite dilution (IGC-FD) were carried out using a PerkinElmer Clarus 400 chromatography meter coupled with an Agilent AMD 1000 flowmeter to control the gas injections. The analysis of recorded chromatograms to obtain the isotherms was conducted using the CGI-CF V 709G software from Adscientis. For the determination of energy distribution functions, the FDRJ 07.5.F software from Adscientis was used. For the measurements at infinite dilution (IGC-ID), C3S-I, C3S-II and C3A samples were placed in a 6.4 mm (1/4 in.) measuring column, with an internal diameter of 4 mm and a length of 10 cm. Approximately 2 g of powder were placed in the columns for measurement. Due to the poor handling properties of the kaolinite and metakaolin powders, compaction, crushing and sieving was carried out beforehand. This procedure ensured a suitable gas flow rate in the IGC column. To do this, kaolinite and metakaolin samples were compacted in a pelletizing mold under a pressure of 1 ton for 2 minutes. Afterwards, the pellets were crushed and sieved. A 3.2 mm (1/8 in.) measuring column, with an internal diameter of 2 mm and a length of 10 cm, was filled with pieces with a size between 250 to 450 m. Approximately 0.35 grams of kaolinite and metakaolinite were used in each case. Before conducting the measurements, the surface of the samples inside the column was conditioned for the tests using a flow of dry helium at 5 mL/min during 16 h at 30°C. Measurements were conducted at 30°C for all samples, except kaolinite. In this case, the retention times observed were extremely long, and the measurement temperature was increased to 80°C on this sample to achieve full elution over a reasonable timeframe. Hexane, heptane, octane, nonane, isooctane, 2,2-dimethyl-hexane (2,2-DHM) and cyclooctane were used as n-alkane probes to determine the dispersive surface energy. Isooctane, 2,2-dimethyl-hexane (2,2-DMH) and cyclooctane were used as branched and cyclic probes to measure the surface nanoroughness. Acetone, acetonitrile (CH3CN), tetrahydrofuran (THF), ether, chloroform (CHCl3) and benzene were also used as polar probes to determine the acid-base character of the different cementitious materials. For IGC-FD measurements, water and isopropanol were used as probes over the set of samples with helium as carrier gas in both cases. Water was initially used over C3A and C3S-I samples. In this case, P/P0 values from 0.15 to 0.64 were explored. A strong interaction of water with the surfaces was observed, and consequently isopropanol was selected as a more suitable adsorbate to conduct further experiments. Measurements with isopropanol were done for C3A, C3S-I, C3S-II, C3S-II Ann, C3S-II-TEA, Kaolinite, MK and MK-TEA. For these measurements, the injected amount of isopropanol was fixed so to achieve a P/P0 up to 0.2, with a minimum of 3 injections. All isopropanol injections were preceded by injection pulse of methane (CH4), used as a reference to compute the retention times (TR) at each point of the chromatogram. All measurements were conducted at 30°C. For all cement phases, a 6.4 mm (1/4 in.) measuring column, with an internal diameter of 4 mm and a length of 10 cm was used. The columns were filled with 1.6-2 g of sample. In the case of C3S-II Annealed, a shorter column (3 cm, filled with 0.6 g of sample) with the same diameter was used to decrease the observed retention time. In the case of clay minerals, a 3.2 mm (1/8 in.) measuring column, with an internal diameter of 2 mm and a length of 5 cm was used, filled with 0.13 to 0.18 g of sample. The clay powders were pelletized in the same way as for the IGC-ID measurements. Isothermal calorimetry was used to characterize the reactivity of the different cement phases. Paste samples were prepared by mixing 15 g of powder with distilled water at a water-to-solids ratio of 0.35. A high shear mixer was used at 1600 rpm for 2 minutes. Afterwards, 10 grams of sample were placed in a glass ampoule and sealed. A TAM Air isothermal calorimeter was used to monitor the heat release of the samples for 7 days at 20°C. Isothermal calorimetry was also used to assess the reactivity of the different clay minerals. For this purpose, the R3 test (ASTM C1897) [16] was selected due to its reliability and ease of interpretation. In this procedure, the different clays are mixed with portlandite, calcium carbonate, potassium sulphate, potassium hydroxide and water at 40 °C, and put into glass ampoules inside the calorimeter at 40 °C. The total heat evolved is taken as a measure of the reactivity of the clays., This paper presents a preliminary study of the characterization of the surface energy properties of clinker phases (C3S and C3A), kaolin and metakaolin by Inverse Gas Chromatography (IGC). For this, a reliable measurement methodology was developed. By looking at changes in the whole series of results (dispersive surface energy, specific polar interaction parameter, acid and base constants, morphology index, nanoroughness and adsorption energy distribution function), it is possible to discern changes between the same powders with different surface treatments. A promising correlation between surface properties and the reactivity of studied materials have been found. However, based on the IGC characterization, the increased reactivity of metakaolin compared to the raw kaolinite seems to be strongly linked to the change in local order rather than significant changes in the surface energetics, although a change in the acid/base nature of the surface has been observed., Swiss Agency of Development and Cooperation (SDC) grant 81026665; Swiss National Science Foundation (SNSF) through an Ambizione fellowship (grant 208719); Consejería de Educación e Investigación (Comunidad de Madrid) which funded the 2016-T1/AMB-1434 project in the frame of “Ayudas de Atracción de Talento Investigador”; Ministry of Science and Innovation through funding PID2020-115797RB-I00/AEI/10.13039/501100011033 project., File List: DRX C3S; PSD_C3SC3A; Calculation KaKb; Data_DI&FC; Data_IGC-FC; Water_AEDF_norm; Water_AEDF, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Research data Set de datos (Dataset)

Rheological Behavior of Oil Well Cement Slurries with Addition of Core/Shell TiO2@SiO2 Nanoparticles—Effect of Superplasticizer and Temperature [Dataset]

  • Batista, Giovanni dos Santos
  • Puertas, Francisca
  • Shigueaki Takimi, Antonio
  • Costa, Eleani Maria da
  • Palacios, Marta
This study investigates the rheological behavior of oil well cement pastes (OWCPs) modified with core/shell TiO2@SiO2 (nTS) nanoparticles and polycarboxylate-ether (PCE) superplasticizers at different temperatures (25, 45, and 60 °C). Results show that nTS particles increased static and dynamic yield stresses and the apparent viscosity of the cement slurries due to an increased solid volume fraction and reduced free water availability. The increase in the slurry dispersion by adding PCE superplasticizers enhanced the effect of the nanoparticles on the rheological parameters. Oscillation rheometry demonstrated that nTS nanoparticles enhanced the structural buildup, while PCE retarded hydration. Furthermore, slurries hydrated at 60 °C experienced higher initial values of the elastic modulus and a faster exponential increase in this rheological parameter due to the acceleration of the cement hydration., This research was partly funded by Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil (CAPES), grant number 001 and PID2020-115797RB-I00/AEI/10.13039/501100011033 (RHEODUR) project., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Impact of pore solution composition and superplasticizers on the interparticle forces and rheology of metakaolin suspensions

  • Real, Sergio
  • Bowen, Paul
  • Moreno, Rodrigo
  • González-Panicello, Laura
  • Puertas, Francisca
  • Hanafi, Mohamed
  • Palacios, Marta
This study focuses on the influence of pH, aqueous phase composition and superplasticizers on the particle interactions in pure metakaolin suspensions. It was found increasing pH up to 11 led to the decrease of the particle agglomeration due to the higher OH− adsorption onto metakaolin particles, which increased the absolute zeta potential and generates higher electrostatic repulsive forces. Above pH = 11, a slight increase in zeta potential was observed and colloidal stability was retained. Metakaolin suspensions prepared in Na2SO4 or Ca(OH)2 at pH = 13 did not agglomerate. However, the simultaneous presence of Ca2+ and SO42−, led to particle agglomeration, which was enhanced as Ca2+ concentration increased. The rise of Ca2+ concentration in suspensions containing Ca2+ and SO42− also induced higher yield stress values in metakaolin suspensions. The addition of polycarboxylate ether (PCE) superplasticizers deagglomerated metakaolin particles and decreased yield stress values in agreement with interparticle force modelling., Authors thank PID2020-115797RB-I00/ AEI/10.13039/501100011033 (RHEODUR) project. C. Alcázar from ICV-CSIC is thanked for her help during the zeta potential measurements. Dr. Lukas Frunz (Sika Technology AG) is thanked for the synthesis of the PCEs., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Research data Set de datos (Dataset)

Evolution of the microstructure of limestone-calcined clay cement pastes exposed to CO2 [Dataset]

  • Pachón Montaño, Alicia
  • González-Panicello, Laura
  • Alonso, M. Cruz
  • Puertas, Francisca
  • Roig-Flores, M.
  • Palacios, Marta
The carbonation and microstructural changes in the pastes were monitored over 1 year (at 1, 30, 90, 180 and 365 days). The evolution of the pore structure of the different cement pastes was characterized by mercury intrusion porosimetry (MIP) with an AutoPore IV 9510 from Micromeritics. The maximum mercury intrusion pressure was set at 60.000 psi, corresponding to a minimum pore diameter of 4 nm. The mercury surface tension and the contact angle between the mercury and the solid surface were 0.484 N/m and 141°, respectively. Previous to this analysis, the samples of 1 x 1 x 2 cm3 were placed in 200 ml of isopropanol over 7 days. Afterwards, the samples were dried in a low vacuum desiccator up to constant weight. The evolution of the mineralogy and microstructure of the non-carbonated and carbonated pastes was also monitored by thermogravimetry (TGA), quantitative X-ray diffraction (QXRD), Fourier Transform infrared spectroscopy (FTIR) and Nuclear Magnetic Resonance (NMR) techniques. Previous to this analysis, pastes were ground by hand mortar and the hydration was stopped by mixing with isopropanol during 1 min in a solid:isopropanol ratio of 1:10 [30],[31]. Thermogravimetry (TGA) was used to determine the amount of bound water, calcium hydroxide and calcium carbonate of the different pastes from the weight loss due their composition on heating. TGA experiments were conducted using a TGA-DSC-DTA Q600 instrument (TA Instruments). Approximately 30 mg of sample in a platinum crucible was heated from 25 °C to 1000 °C at a rate of 10 °C/min under a flow of N2 at 100 mL/min. Crystalline phases were analysed by X-ray diffraction (XRD) using a D8 ADVANCE diffractometer (BRUKER-AXS, Billerica, MA, USA) in a θ-2θ configuration with Cu-Kα1 and Cu-Kα2 radiation (1.5406 Å and 1.5444 Å). The samples were scanned between 5° and 70°, with a step size of 0.01973° and using an ultra-fast RX “Lynxeye” detector, which includes a 3 mm anti-scatter slit, a 2.5° Soller second slit, and a Ni K-beta filter (0.5%). Crystalline phases were identified using DIFFRACT.EVA V4.2.1 software in conjunction with the Crystallography Open Database (COD) and crystalline and amorphous phases were quantified using the Rietveld method with Topas 5 software from Bruker. Amorphous content was determined using the internal standard method and 20%wt of corundum (Al₂O₃ was added to each sample). The corundum was prepared from 99.9%wt purity α-phase Al₂O₃ (Thermo Scientific) and subjected to a thermal treatment, at a heating rate of 13 °C/min up to 1600 °C, held at 1600 °C for one hour, and then allowed to cool naturally to room temperature inside the furnace., Fourier-transform infrared (FTIR) spectra acquired using a Nicolet 6700 spectrometer (Thermo Scientific, Madison, USA). KBr pellets were prepared by mixing 1 mg of the sample with 200 mg of KBr. The spectra were recorded over a frequency range of 4000 to 400 cm⁻¹, with a resolution of 4 cm⁻¹. These spectra allow to identify band shifts in the silicate region, which could indicate modifications in the polymerisation of the C-S-H/C-A-S-H. This technique provided also additional information about the polymorphism of the CaCO3 formed. Carbonated and non-carbonated pastes were also analyzed using 29Si and 27Al MAS NMR. A Bruker AVANCE-400 spectrometer operating at a 9.4 T magnetic field was used. A 4 mm (outer diameter) ZrO₂ rotor was employed, spinning at a frequency of 10 kHz. 29Si MAS NMR spectra were recorded at a resonance frequency of 79.49 MHz, with a pulse length of 5 μs, a recycle delay of 10 s, and 6000 scans for each measurement. 27Al MAS NMR spectra were recorded at a resonance frequency of 104.26 MHz, with a pulse length of 2 μs, a recycle delay of 5 s, and 720 scans for each measurement., After the 28 days of curing and prior to start the carbonation process, all the samples were preconditioned in controlled environment chamber at 23 oC and a relative humidity of 70% ± 2% RH, achieved using saturated potassium iodide (KI) solutions. To keep the interior of the chamber free of CO2, soda lime was placed inside. After the two-week period, half of the samples were placed in an environment controlled chamber with 1%wt CO2, a relative humidity of 70% ± 2% RH and 23 oC. Additionally, the other half of the samples were kept in a separate chamber at a RH= 70% ± 2% and 23 oC to study the evolution of hydration over time. Soda lime was placed in this chamber to ensure the non-carbonation of these samples. The monitorization of the microstructure and hydration of these samples in a free-CO2 atmosphere will allow to better identify the changes induced in carbonated samples attributed to hydration or carbonation., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Evolution of the microstructure of limestone-calcined clay cement pastes exposed to CO2

  • Pachón Montaño, Alicia
  • González-Panicello, Laura
  • Alonso, M. Cruz
  • Puertas, Francisca
  • Roig-Flores, M.
  • Palacios, Marta
The datasets generated and analyzed during the current study are available in the DIGITAL.CSIC repository, https://doi.org/10.20350/digitalCSIC/18511., The aim of this study was to gain a deeper understanding of the carbonation resistance of binary and ternary calcined clay-blended cements, and to investigate how this resistance correlates with their microstructure and phase assemblage. A lower carbonation resistance was observed for calcined clay-containing cement pastes compared to OPC, which can be attributed to their lower contents of CaO reactive and portlandite. Keeping constant the clinker content of the blend, in limestone-calcined clay cements (LC<sup>3</sup>) pastes, the increase of the amount of metakaolin increased their carbonation resistance. Additionally, the presence of limestone in the ternary blends, which promotes the formation of carboaluminate phases, appears to play a positive role in enhancing the carbonation resistance of the calcined clay-blended cements. After 6 months of exposure of the pastes to 1 wt% CO<inf>2</inf>, C-A-S-H formed in calcined clay blended cements suffered a substantial decomposition, leading to the formation of an aluminosilicate gel and a coarsening of the pore structure. In contrast, no significant decomposition of C-A-S-H was observed in the OPC pastes under the same conditions. Regarding the CaCO<inf>3</inf> polymorphism, calcite was the major polymorphism formed in all cases, although vaterite was also identified in both the binary and ternary calcined clay-blended cements., Grants PID2020\u2013115797RB-I00 and PID2023\u2013149927OB-I00 funded by MICIU / AEI / 10.13039/501100011033 and MICIU/AEI/ 10.13039/501100011033/FEDER , UE, respectively., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

An integrated multi-omics approach identifies the landscape of interferon-α-mediated responses of human pancreatic beta cells

  • Colli, Maikel Luis
  • Ramos-Rodríguez, Mireia
  • Raurell Vila, Helena
  • Pasquali, Lorenzo
  • Eizirik, Décio L.
Interferon-α (IFNα), a type I interferon, is expressed in the islets of type 1 diabetic individuals, and its expression and signaling are regulated by T1D genetic risk variants and viral infections associated with T1D. We presently characterize human beta cell responses to IFNα by combining ATAC-seq, RNA-seq and proteomics assays. The initial response to IFNα is characterized by chromatin remodeling, followed by changes in transcriptional and translational regulation. IFNα induces changes in alternative splicing (AS) and first exon usage, increasing the diversity of transcripts expressed by the beta cells. This, combined with changes observed on protein modification/degradation, ER stress and MHC class I, may expand antigens presented by beta cells to the immune system. Beta cells also up-regulate the checkpoint proteins PDL1 and HLA-E that may exert a protective role against the autoimmune assault. Data mining of the present multi-omics analysis identifies two compound classes that antagonize IFNα effects on human beta cells., This work was supported by grants from the Fonds National de la Recherche Scientifique (FNRS), Welbio CR-2015A-06 and CR-2019C-04, Belgium; the Horizon 2020 Program, T2Dsystems (GA667191); the National Institutes of Health, NIH-NIDDK-HIRN Consortium 1UC4DK104166-01 and Innovate2CureType1 - Dutch Diabetes Research Fundation (DDRF). D.L.E. and P.M. have received funding from the Innovative Medicines Initiative 2 Joint Undertaking under Grant Agreement No. 115797 (INNODIA). This Joint Undertaking receives support from the Union’s Horizon 2020 research and innovation programme and “EFPIA”, “JDRF” and “The Leona M. and Harry B. Helmsley Charitable Trust”. The DiViD study is funded by The South-Eastern Norway Regional Health Authority (grant to K.D.-J.), the Novo Nordisk Foundation (grant to K.D.-J.), and through the PEVNET (Persistent Virus Infection in Diabetes Network) Study Group funded by the European Union’s Seventh Framework Programme (FP7/2007-2013) under grant Agreement Number 261441 PEVNET. Additional support was from a JDRF Career Development Award (5-CDA-2014-221-A-N) to S.J.R., a JDRF research grant awarded to the network of Pancreatic Organ Donors – Virus (nPOD-V) consortium (JDRF 25-2012-516); an MRC Project Grant MR/P010695/1 awarded to S.J.R. and N.G.M., a studentship grant from the Norman Family Trust (to S.J.R. and N.G.M.), a Spanish Ministry of Economy and Competiveness (SAF2017-86242-R to L.P.) and Marató TV3 (201624.10 to L.P.). L.P. is a recipient of a Ramon y Cajal contract from the Spanish Ministry of Economy and Competitiveness (RYC-2013-12864) and M.R. is supported by an FI Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR) PhD fellowship.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Genome editing of human pancreatic beta cell models: problems, possibilities and outlook

  • Balboa, Diego
  • Prasad, Rashmi B.
  • Groop, Leif
  • Otonkoski, Timo
Understanding the molecular mechanisms behind beta cell dysfunction is essential for the development of effective and specific approaches for diabetes care and prevention. Physiological human beta cell models are needed for this work. We review the possibilities and limitations of currently available human beta cell models and how they can be dramatically enhanced using genome-editing technologies. In addition to the gold standard, primary isolated islets, other models now include immortalised human beta cell lines and pluripotent stem cell-derived islet-like cells. The scarcity of human primary islet samples limits their use, but valuable gene expression and functional data from large collections of human islets have been made available to the scientific community. The possibilities for studying beta cell physiology using immortalised human beta cell lines and stem cell-derived islets are rapidly evolving. However, the functional immaturity of these cells is still a significant limitation. CRISPR-Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated protein 9) has enabled precise engineering of specific genetic variants, targeted transcriptional modulation and genome-wide genetic screening. These approaches can now be exploited to gain understanding of the mechanisms behind coding and non-coding diabetes-associated genetic variants, allowing more precise evaluation of their contribution to diabetes pathogenesis. Despite all the progress, genome editing in primary pancreatic islets remains difficult to achieve, an important limitation requiring further technological development., The authors’ work in this area has been supported by grants from the Academy of Finland, The Novo Nordisk Foundation and the Sigrid Jusélius Foundation. TO is also funded by the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement no. 115797 (INNODIA), which receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA), JDRF and the Leona M. and Harry B. Helmsley Charitable Trust.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

The type 1 diabetes gene TYK2 regulates β-cell development and its responses to interferon-α

  • Chandra, Vikash
  • Ibrahim, Hazem
  • Halliez, Clémentine
  • Prasad, Rashmi B.
  • Vecchio, Federica
  • Dwivedi, Om Prakash
  • Kvist, Jouni
  • Balboa, Diego
  • Saarimäki-Vire, Jonna
  • Montaser, Hossam
  • Barsby, Tom
  • Lithovius, Väinö
  • Artner, Isabella
  • Gopalakrishnan, Swetha
  • Groop, Leif
  • Mallone, Roberto
  • Eizirik, Décio L.
  • Otonkoski, Timo
Type 1 diabetes (T1D) is an autoimmune disease that results in the destruction of insulin producing pancreatic β-cells. One of the genes associated with T1D is TYK2, which encodes a Janus kinase with critical roles in type-Ι interferon (IFN-Ι) mediated intracellular signalling. To study the role of TYK2 in β-cell development and response to IFNα, we generated TYK2 knockout human iPSCs and directed them into the pancreatic endocrine lineage. Here we show that loss of TYK2 compromises the emergence of endocrine precursors by regulating KRAS expression, while mature stem cell-islets (SC-islets) function is not affected. In the SC-islets, the loss or inhibition of TYK2 prevents IFNα-induced antigen processing and presentation, including MHC Class Ι and Class ΙΙ expression, enhancing their survival against CD8+ T-cell cytotoxicity. These results identify an unsuspected role for TYK2 in β-cell development and support TYK2 inhibition in adult β-cells as a potent therapeutic target to halt T1D progression., We gratefully acknowledge Dr. Fatoumata Samassa for help with cytotoxicity assays. We thank Jarkko Ustinov for the insulin and c-peptide ELISA measurements. S. Eurola, H. Grym, and A. Laitinen are thanked for expert technical support. We thank FIMM Single Cell Analytics unit (supported by HiLIFE and Biocentre Finland) for single cell RNA sequencing services. We want to acknowledge the participants and investigators of the FinnGen study. T.O. acknowledges the funding provided by the Academy of Finland (MetaStem Center of Excellence grant 312437), the Novo Nordisk Foundation and the Sigrid Juselius Foundation. R.M. acknowledges the support of the Agence Nationale de la Recherche (ANR-19-CE15-0014-01) and the Fondation pour la Recherche Medicale (EQU20193007831). C.H. was funded by an Année Recherche fellowship of the Paris Saclay University. F.V. was funded by an international PhD fellowship of the IdEx Université de Paris. R.B.P. acknowledges the funding by Hjelt foundation, Crafoord foundation (2020089) and Swedish Research Council (2021-02623). D.L.E. acknowledges the support of grants from the Welbio-FNRS (Fonds National de la Recherche Scientifique; WELBIO-CR-2019C-04), Belgium; the Innovate2CureType1—Dutch Diabetes Research Foundation (DDRF), Holland; the Juvenile Diabetes Foundation (JDRF; 2-SRA-2019-834-S-B); the NIH (HIRN-CBDS) grant U01 DK127786, USA. D.L.E., T.O., and R.M. acknowledge support from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreements No 115797 (INNODIA) and 945268 (INNODIA HARVEST), supported by the European Union’s Horizon 2020 research and innovation programme. These Joint Undertakings receive support from the Union’s Horizon 2020 research and innovation programme and “EFPIA”, “JDRF” and “The Leona M. and Harry B. Helmsley Charitable Trust”.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

The impact of proinflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes

  • Ramos-Rodríguez, Mireia
  • Raurell Vila, Helena
  • Colli, Maikel Luis
  • Alvelos, Maria Inês
  • Subirana-Granés, Marc
  • Juan-Mateu, Jonàs
  • Norris, Richard
  • Turatsinze, Jean-Valery
  • Nakayasu, Ernesto S.
  • Webb-Robertson, Bobbie-Jo M.
  • Inshaw, Jamie R. J.
  • Marchetti, Piero
  • Piemonti, Lorenzo
  • Esteller, Manel
  • Todd, John A.
  • Metz, Thomas O.
  • Eizirik, Décio L.
  • Pasquali, Lorenzo
The early stages of type 1 diabetes (T1D) are characterized by local autoimmune inflammation and progressive loss of insulin-producing pancreatic β cells. Here we show that exposure to proinflammatory cytokines reveals a marked plasticity of the β-cell regulatory landscape. We expand the repertoire of human islet regulatory elements by mapping stimulus-responsive enhancers linked to changes in the β-cell transcriptome, proteome and three-dimensional chromatin structure. Our data indicate that the β-cell response to cytokines is mediated by the induction of new regulatory regions as well as the activation of primed regulatory elements prebound by islet-specific transcription factors. We find that T1D-associated loci are enriched with newly mapped cis-regulatory regions and identify T1D-associated variants disrupting cytokine-responsive enhancer activity in human β cells. Our study illustrates how β cells respond to a proinflammatory environment and implicate a role for stimulus response islet enhancers in T1D., L.Pasquali was supported by grants from the Spanish Ministry of Economy and Competitiveness (nos. BFU2014-58150-R and SAF2017-86242-R), Marató TV3 (no. 201624.10) and a young investigator award from the Spanish Society of Diabetes (Ayuda SED a Proyectos de Investigación, no. 2017-SED). L.Pasquali is a recipient of a Ramon y Cajal contract from the Spanish Ministry of Economy and Competitiveness (no. RYC-2013-12864). The Pasquali lab is further supported by Instituto de Salud Carlos III (no. PIE16/00011). M.R. is supported by an FI Agència de Gestió d’Ajuts Universitaris i de Recerca PhD fellowship (no. 2019FI_B100203). J.J. was supported by a Marie Skłodowska-Curie Actions fellowship grant from the Horizons 2020 European Union (EU) Programme (project no. 660449). M.I.A. was supported by a FRIA fellowship from the Fonds de la Recherche Scientifique (FNRS) (no. 26410496). Human islets were provided through the European Consortium for Islet Transplantation distribution program for basic research supported by JDRF (no. 31-2008-416). D.L.E. was supported by the Walloon Region through the FRFS-WELBIO Fund for Strategic Fundamental research (no. CR-2015A-06s and CR-2019C-04) and by grants from the Fonds National de la Recherche Scientifique (no. T003613F), the Horizon 2020 Programme (project T2Dsystems, no. GA667191), Brussels Capital Region Innoviris (project DiaType, no. 2017-PFS-24), Dutch Diabetes Research Fundation (project Innovate2CureType1, DDRF; no. 2018.10.002) and the Innovative Medicines Initiative 2 Joint Undertaking (project INNODIA, no. 115797). This Innovative Medicines Initiative 2 Joint Undertaking receives support from the EU’s Horizon 2020 Research and Innovation Programme and European Federation of Pharmaceutical Industries and Associations, JDRF and the Leona M. and Harry B. Helmsley Charitable Trust (project INNODIA, no. 115797). T.O.M. and D.L.E. were supported by a grant from the National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases-Human Islet Research Network Consortium (no. 1UC4DK104166-01). Part of the work was performed at the Environmental Molecular Sciences Laboratory, a US Department of Energy national scientific user facility located at Pacific Northwest National Laboratory. Battelle operates the Pacific Northwest National Laboratory for the Department of Energy (contract no. DE-AC05-76RLO01830).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

An integrated multi-omics approach identifies the landscape of interferon-α-mediated responses of human pancreatic beta cells

  • Colli, Maikel L.|||0000-0002-2200-4761
  • Ramos Rodríguez, Mireia|||0000-0001-8083-2445
  • Nakayasu, Ernesto S.|||0000-0002-4056-2695
  • Alvelos, Maria I.
  • Lopes, Miguel
  • Hill, Jessica L. E.
  • Turatsinze, Jean-Valery|||0000-0001-9492-6274
  • Coomans de Brachène, Alexandra
  • Russell, Mark A.
  • Raurell Vila, Helena|||0000-0003-1196-836X
  • Castela, Angela
  • Juan-Mateu, Jonàs
  • Webb-Robertson, Bobbie-Jo M.
  • Krogvold, Lars
  • Dahl-Jorgensen, Knut
  • Marselli, Lorella|||0000-0002-6698-2962
  • Marchetti, Piero
  • Richardson, Sarah J.|||0000-0002-1160-6062
  • Morgan, Noel G.|||0000-0003-1537-8113
  • Metz, Thomas O.|||0000-0001-6049-3968
  • Pasquali, Lorenzo|||0000-0003-2423-1826
  • Eizirik, Décio L.|||0000-0003-2453-5889
Interferon-α (IFNα), a type I interferon, is expressed in the islets of type 1 diabetic individuals, and its expression and signaling are regulated by T1D genetic risk variants and viral infections associated with T1D. We presently characterize human beta cell responses to IFNα by combining ATAC-seq, RNA-seq and proteomics assays. The initial response to IFNα is characterized by chromatin remodeling, followed by changes in transcriptional and translational regulation. IFNα induces changes in alternative splicing (AS) and first exon usage, increasing the diversity of transcripts expressed by the beta cells. This, combined with changes observed on protein modification/degradation, ER stress and MHC class I, may expand antigens presented by beta cells to the immune system. Beta cells also up-regulate the checkpoint proteins PDL1 and HLA-E that may exert a protective role against the autoimmune assault. Data mining of the present multi-omics analysis identifies two compound classes that antagonize IFNα effects on human beta cells.